Illumina, Inc.

Healthcare · Diagnostics & Research · United States

Last price 235.99 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 35.68B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole...